HALO - Halozyme Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
57,936
168,740
66,764
43,292
Short Term Investments
296,590
300,474
138,217
65,047
Total Cash
354,526
469,214
204,981
108,339
Net Receivables
30,005
22,133
15,680
32,410
Inventory
22,625
5,146
14,623
9,489
Other Current Assets
-
0
0
0
Total Current Assets
427,849
510,372
256,532
171,772
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
23,704
17,410
16,183
14,261
Accumulated Depreciation
-16,239
-13,890
-11,919
-10,318
Net property, plant and equipment
7,465
3,520
4,264
3,943
Equity and other investments
-
-
-
-
Goodwill
-
-
-
-
Intangible Assets
-
-
-
-
Other long-term assets
500
500
500
500
Total non-current assets
12,399
9,573
4,983
10,017
Total Assets
440,248
519,945
261,515
181,789
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
91,506
77,211
17,393
21,862
Accounts Payable
4,079
7,948
3,578
4,499
Taxes payable
-
-
-
-
Accrued liabilities
49,529
39,601
28,821
26,792
Deferred revenues
4,247
6,568
4,793
9,304
Other Current Liabilities
-
0
0
0
Total Current Liabilities
149,361
131,328
54,585
62,457
Non-current liabilities
Long Term Debt
34,874
125,140
199,228
27,971
Deferred taxes liabilities
-
-
-
-
Deferred revenues
5,008
54,297
39,825
43,919
Other long-term liabilities
2,118
814
358
4,443
Total non-current liabilities
42,000
180,251
239,411
76,333
Total Liabilities
191,361
311,579
293,996
138,790
Stockholders' Equity
Common Stock
145
143
130
128
Retained Earnings
-531,438
-522,371
-585,342
-482,658
Accumulated other comprehensive income
-277
-450
-6
-99
Total stockholders' equity
248,887
208,366
-32,481
42,999
Total liabilities and stockholders' equity
440,248
519,945
261,515
181,789